ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,158.00
0.72%
Dow Jones
38,686.32
0.00%
Brent Oil
81.135
0.41%
Bitcoin
69,122.79
2.03%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/03/20248:04AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:LPTVLoop Media Inc
06/03/20248:04AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AIRIAir Industries Group
06/03/20248:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBWMMercantile Bank Corporation
06/03/20248:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IIVIPCoherent Corporation
06/03/20248:04AMBusiness WireHyatt’s Growth Momentum Continues With Record Global Pipeline of 129,000 RoomsNYSE:HHyatt Hotels Corporation
06/03/20248:04AMPR Newswire (US)TÜV Rheinland's Northeast Technology & Innovation Center receive accreditation to verify equipment to be imported into Korea and other significant accreditations
06/03/20248:03AMAlliance NewsAlliance NewsFranchise Brands sees top-end 2023 earnings and plans dividend boostLSE:FRANFranchise Brands Plc
06/03/20248:03AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ELEstee Lauder Companies Inc
06/03/20248:03AMBusiness WireGrace Science, LLC Selected by FDA to Participate in the START Pilot Program for GS-100 Gene Therapy for NGLY1 Deficiency and Announcement of the Successful Treatment of the 2nd Patient
06/03/20248:03AMPR Newswire (Canada)U.S.-based Lithium Producer International Battery Metals (IBAT) Names Iris Jancik as CEO to Lead Global Commercial Expansion
06/03/20248:02AMGlobeNewswire Inc.Ready Capital to Present at Nareit’s REITweek 2024NYSE:RCReady Capital Corporation 65
06/03/20248:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:CHTChunghwa Telecom Co Ltd
06/03/20248:02AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:LPTVLoop Media Inc
06/03/20248:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ILPTIndustrial Logistics Properties Trust
06/03/20248:02AMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces Participation at Upcoming Investor ConferenceNASDAQ:RYTMRhythm Pharmaceuticals Inc
06/03/20248:02AMPR Newswire (US)MIT Sloan Management Review Research Examines Circular Business Models' Benefit to Bottom Line and Increased Sustainability Measures
06/03/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
06/03/20248:01AMGlobeNewswire Inc.Texas Must Close Primary Elections
06/03/20248:01AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RFACWRF Acquisition Corporation
06/03/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
06/03/20248:01AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FUTUFutu Holdings Ltd
06/03/20248:01AMGlobeNewswire Inc.Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024NASDAQ:MYNZMainz BioMed NV
06/03/20248:01AMPR Newswire (US)Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment StudiesNASDAQ:AEMDAethlon Medical Inc
06/03/20248:01AMPR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - OPTI
06/03/20248:00AMGlobeNewswire Inc.Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual MeetingTSX:MDNAMedicenna Therapeutics Corp
06/03/20248:00AMGlobeNewswire Inc.Genesis Offers New Tools and Incentives to Financial Industry Software Developers
06/03/20248:00AMGlobeNewswire Inc.Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease TherapiesNASDAQ:DNLIDenali Therapeutics Inc
06/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:ZNOGWZion Oil and Gas Inc (PK)
06/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RFACWRF Acquisition Corporation
06/03/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:IRTIndependence Realty Trust Inc

Your Recent History

USOTC
THNBY
Technoprobe (PK)
COIN
XNBGBP
USOTC
VIEGF
Waypoint REIT (PK)
TSX
TOT
Total Energy Services
NASDAQ
TRCA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved